EUVIMEDEUVIMED entdecken
Crossref

The effect of different therapies and complete blood cell count-derived inflammatory biomarkers on the prognosis of Stevens-Johnson syndrome and toxic epidermal necrolysis

Pei-Yu Wang, Tian-Hang Yu, Guang-Wen Yin, Lin-Feng Li

Clinical and Experimental Dermatology · 2026

DOI: 10.1093/ced/llag088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2026. Verfasst von Pei-Yu Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome, Adalimumab, Immunoglobulins, Intravenous, Adrenal Cortex Hormones.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous adverse drug reactions still with controversy in treatment. Complete blood cell count (CBC)-derived inflammatory biomarkers reflect systemic inflammation, and their value in SJS/TEN has not been fully studied.

Objective

To compare the therapeutic efficacy of corticosteroid combined with adalimumab (CA), corticosteroid combined with IVIG (CI) and corticosteroid monotherapy (CM), and explore prognosticators on severity and prognosis of SJS/TEN.

Methods

All SJS/TEN inpatients treated with CA, CI, or CM in two hospitals between 2015 and 2024 were studied. We calculated biomarkers including neutrophil/lymphocyte ratio (NLR), derived neutrophil/(leukocyte minus neutrophil) ratio (dNLR), monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), and neutrophil/(lymphocyte × platelet) ratio (NLPR), and analyzed their correlations with severity and prognosis.

Results

Among 136 patients, 29 patients were treated with CA, 18 patients were treated with CI, and 89 patients were treated with CM. The mortality rate in three groups was much lower than expected based on SCORTEN. The time to original lesions improvement and time to no new lesions developing in CA and CI were significantly shorter than those in CM. NLR, dNLR, PLR, and NLPR were independent risk factors for the elevation of SCORTEN score, and MLR was an independent prognostic factor for healing time.

Conclusions

The therapeutic efficacy of CA and CI is better than CM, and the incidence of complications is not increased. NLR, dNLR, PLR, and NLPR may serve as potential prognosticators of severity in SJS/TEN. Higher MLR appears to be a potential poor prognostic factor for healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stevens-Johnson SyndromeAdalimumabImmunoglobulins, IntravenousAdrenal Cortex HormonesHumansFemaleMalePrognosisBiomarkersMiddle AgedAdultDrug Therapy, CombinationSeverity of Illness IndexBlood Cell CountAgedNeutrophilsTreatment OutcomeRetrospective StudiesAnti-Inflammatory Agents

Substanzen

BiomarkersAdalimumabImmunoglobulins, IntravenousAdrenal Cortex HormonesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of Dermatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Zitieren

APA

Wang, P. Y., Yu, T. H., Yin, G. W., & Li, L. F. (2026). The effect of different therapies and complete blood cell count-derived inflammatory biomarkers on the prognosis of Stevens-Johnson syndrome and toxic epidermal necrolysis. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag088

Vancouver

Wang PY, Yu TH, Yin GW, Li LF. The effect of different therapies and complete blood cell count-derived inflammatory biomarkers on the prognosis of Stevens-Johnson syndrome and toxic epidermal necrolysis. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag088

BibTeX
@article{Wang2026,
  author = {Wang, Pei-Yu and Yu, Tian-Hang and Yin, Guang-Wen and Li, Lin-Feng},
  title = {The effect of different therapies and complete blood cell count-derived inflammatory biomarkers on the prognosis of Stevens-Johnson syndrome and toxic epidermal necrolysis},
  journal = {Clinical and Experimental Dermatology},
  year = {2026},
  doi = {10.1093/ced/llag088}
}
Kostenlos starten →